avrg: GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hoxa13 | mm10_v2_chr6_-_52260822_52260880 | -0.64 | 2.7e-05 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_-_61674094 Show fit | 26.99 |
ENSMUST00000098040.3
|
major urinary protein 18 |
|
chr4_-_61303802 Show fit | 23.50 |
ENSMUST00000125461.1
|
major urinary protein 14 |
|
chr4_-_61303998 Show fit | 22.16 |
ENSMUST00000071005.8
ENSMUST00000075206.5 |
major urinary protein 14 |
|
chr4_-_61439743 Show fit | 18.15 |
ENSMUST00000095049.4
|
major urinary protein 15 |
|
chr4_-_61519467 Show fit | 17.91 |
ENSMUST00000095051.5
ENSMUST00000107483.1 |
major urinary protein 16 |
|
chr4_-_61228271 Show fit | 17.78 |
ENSMUST00000072678.5
ENSMUST00000098042.3 |
major urinary protein 13 |
|
chr4_-_60070411 Show fit | 17.46 |
ENSMUST00000079697.3
ENSMUST00000125282.1 ENSMUST00000166098.1 |
major urinary protein 7 |
|
chr4_-_60662358 Show fit | 16.46 |
ENSMUST00000084544.4
ENSMUST00000098046.3 |
major urinary protein 11 |
|
chr4_-_61595871 Show fit | 16.41 |
ENSMUST00000107484.1
|
major urinary protein 17 |
|
chr4_-_60222580 Show fit | 16.34 |
ENSMUST00000095058.4
ENSMUST00000163931.1 |
major urinary protein 8 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 31.8 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
3.9 | 15.5 | GO:0034760 | negative regulation of iron ion transport(GO:0034757) negative regulation of iron ion transmembrane transport(GO:0034760) |
1.2 | 13.6 | GO:0070189 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
1.0 | 11.0 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
3.6 | 10.9 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.5 | 10.5 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.4 | 9.7 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.5 | 8.7 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.5 | 7.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.8 | 6.7 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 27.0 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 15.4 | GO:0043235 | receptor complex(GO:0043235) |
0.1 | 11.2 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 9.4 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 8.9 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 8.8 | GO:0070469 | respiratory chain(GO:0070469) |
1.9 | 7.6 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.3 | 6.7 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 6.6 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.8 | 6.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.1 | 15.3 | GO:0005009 | insulin-activated receptor activity(GO:0005009) pheromone activity(GO:0005186) |
0.6 | 14.2 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 11.1 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
2.8 | 11.0 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.1 | 10.4 | GO:0005496 | steroid binding(GO:0005496) |
3.4 | 10.3 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
1.5 | 10.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 9.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
1.7 | 8.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.3 | 7.7 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 6.1 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 6.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 6.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 5.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 4.9 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 4.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 3.9 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 3.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 3.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 2.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 13.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.2 | 10.5 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 8.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 7.6 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 6.8 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.2 | 5.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 5.3 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 5.0 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.4 | 4.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 4.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |